产品详情
简单介绍：
重组大鼠巨噬细胞衍生的趋化因子/ CCL22蛋白与其它公司提供的重组蛋白不同，rRtMDC/CCL22蛋白产品为采用CFS的无细胞麦胚蛋白合成系统表达出来的重组蛋白，可表达出对细胞有毒性、易被蛋白酶降解的蛋白；并获得具有良好的可溶性，并有翻译后修饰、从而部分具有功能的蛋白.同时独有的全自动蛋白纯化技术则简便高效，将蛋白纯化过程中对蛋白的损伤降低到*小程度.重组大鼠巨噬细胞衍生的趋化因子/ CCL22蛋白（全长序列）产品可用于Western Blot验证、抗体制备、蛋白检测、ELISA等试验中.
详情介绍：
重组大鼠巨噬细胞衍生的趋化因子/ CCL22蛋白
| Synonyms | STCP-1, MDC (1-69), Macrophage-derived Chemokine |
| Species | Rat |
| Source | Escherichia coli. |
| Molecular Weight | Approximately 7.9 kDa, a single, non-glycosylated polypeptide chain containing 68 amino acids. |
| Quantity | 5µg/20µg/1000µg |
| AA Sequence | 重组大鼠巨噬细胞衍生的趋化因子/ CCL22蛋白GPYGANVEDS ICCQDYIRHP LPPRFVKEFY WTSKSCRKPG VVLITIKNRD ICADPRMLWV KKILHKLA |
| Purity | > 96 % by SDS-PAGE and HPLC analyses. |
| Biological Activity | Fully biologically active when compared to standard. The biologically active determined by a chemotaxis bioassay using human T-lymphocytes is in a concentration range of 10-100 ng/ml. |
| Physical Appearance | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Formulation | 重组大鼠巨噬细胞衍生的趋化因子/ CCL22蛋白Lyophilized from a 0.2 µm filtered concentrated solution in 2 × PBS, pH7.4. |
| Endotoxin | Less than 1 EU/µg of rRtMDC/CCL22 as determined by LAL method. |
| Reconstitution | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/ml. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions. |
| Storage | 重组大鼠巨噬细胞衍生的趋化因子/ CCL22蛋白This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C. Avoid repeated freeze/thaw cycles. |
| 重组大鼠巨噬细胞衍生的趋化因子/ CCL22蛋白 | |
| SDS-PAGE |  |
| Reference | 1. Nomiyama H, Imai T, Kusuda J, et al. 1998. Cytogenet Cell Genet, 81: 10-1. 2. Godiska R, Chantry D, Raport CJ, et al. 1997. J Exp Med, 185: 1595-604. 3. Yamashita UandKuroda E. 2002. Crit Rev Immunol, 22: 105-14. 4. Katou F, Ohtani H, Nakayama T, et al. 2001. Am J Pathol, 158: 1263-70. |
| Background | CCL22 is a protein encoded by the CCL22 gene. It is highly expressed in macrophage, monocyte-derived dendritic cell and thymus, additionally, also detected in the tissues of thymus, lymph node and appendix. CCL22 can bind to CCR4, and is a chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells, but not for neutrophils, eosinophils, and resting T-lymphocytes. After secreted from monocyte-derived dendritic cells, the protein can be proteolytic cleaved into three forms: MDC (3-69), MDC (5-69), MDC (7-69). |
